Search results for: disease
‘Gut disorders may be early warning signs of Parkinson’s disease’
Digestive issues such as constipation, dysphagia and irritable bowel syndrome (IBS) may be precursors of Parkinson's disease, according to research published in the journal...
AstraZeneca to stop developing Crohn’s disease drug
British drugmaker AstraZeneca said on Thursday (June 1) it would stop developing its drug brazikumab to treat inflammatory bowel diseases, including Crohn's disease and ulcerative...
Chiesi Farmaceutici acquires Amryt Pharma to develop innovative treatment for rare diseases
Chiesi Farmaceutici, the international, research-focused biopharmaceuticals and healthcare group has acquired Amryt Pharma, a global biopharmaceutical company dedicated to developing novel treatments for rare...
Researchers shed new light on treatment of Alzheimer’s disease
According to Alzheimer 's Disease International, more than 55 million people worldwide will have Alzheimer's disease by 2020. This figure will nearly double every...
Amgen to acquire rare disease specialist Horizon in biggest buyout of year
Amgen Inc on Monday agreed to buy Horizon Therapeutics Plc in a deal valued at $27.8 billion (£22.67bn), fortifying its rare diseases portfolio in...
Eisai, Biogen Alzheimer’s disease drug could be available to some as early as next year
Japanese pharmaceutical firm Eisai Co plans to seek full approval of its experimental Alzheimer's drug lecanemab in the United States, Europe and Japan armed with...